In addition, BCR–ABL1-independent resistance to IM has been associated with transcription factor NF-κB, protein kinase C, and HDACs in CML, but not with BCR–ABL1 [57,58,59]. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.